You are here NBIRR Guide Statistics
Monday, September 25, 2017

  • From Consensus Conference on Hyperbaric Oxygen Therapy in Traumatic Brain Injury. October 2008.  “Side effects from HBOT are uncommon and severe or permanent complications are rare, especially at the doses of HBOT used “off-label” for TBI patients (approximately 1.5 atm abs for 60 minutes).” This is the protocol that will be used in NBIRR.
  • TBI has been called the signature wound of the Wars in Iraq and Afghanistan. A RAND Corporation study released in April "estimates that about 320,000 service members may have experienced a traumatic brain injury during deployment - the term used to describe a range of injuries from mild concussions to severe penetrating head wounds. Just 43 percent reported ever being evaluated by a physician for that injury. One-year estimates of the societal cost associated with treated cases of mild traumatic brain injury range up to $32,000 per case, while estimates for treated moderate to severe cases range from $268,000 to more than $408,000. Estimates of the total one-year societal cost of the roughly 2,700 cases of traumatic brain injury identified to date range from $591 million to $910 million."
  • CBS News reports that in 2005, in just those 45 states, there were at least 6,256 suicides among those who served in the armed forces. That’s 120 each and every week, 17 a day, in just one year.
  • TBIs contribute to a substantial number of deaths and cases of permanent disability annually. CDC estimates that at least 5.3 million Americans, about 2% of the U.S. population, currently have a long-term or lifelong need for help to perform activities of daily living as a result of a TBI.
  • Hyperbaric Oxygen Therapy is approved for use in the U.S. for many conditions, but not for TBI or PTSD. Yet, worldwide, hundreds of thousands of treatments every year are administered for a variety of debilitating conditions, in a safe and effective manner.
  • On March 3, 2009, at the House Defense Appropriations Subcommittee Hearing on TBI and Psychological Health, Ms. Ellen Embrey, Deputy Assistant Secretary of Defense, Force Health Protection, stated that DoD is not paying for Hyperbaric Medical Treatments for TBI and PTSD because the DoD policy is not to pay for any off-label use of drugs. That is clearly not an accurate statement, as every drug except Zoloft being used for PTSD and every drug being used for TBI has never been FDA labeled for those conditions. In addition the side-effects of many of these psychoactive drugs are significant and many are FDA Black Labeled as causing a potential increased suicide risk. As suicide is a major concern to Congress and the American people, the wide-spread use of these drugs off-label for TBI/PTSD symptoms may be a contributing factor. HBOT 1.5, though off-label, has caused significant improvement in every combat veteran treated to date, and has none of these side effects.
  • Based on data reported to the Department of Defense and Veteran's Brain Injury Center (DVBIC), currently approximately 200-250 Marines a month are newly diagnosed with a Traumatic Brain Injury.  Many of these Marines are receiving their diagnosis of a TBI as a result of battlefield events that occurred as early as 2005.
  • In 2003, *Medicare approved reimbursement for hyperbaric oxygen therapy *because it prevented 75% of all amputations for diabetic foot wounds. Today hospitals across the nation are preventing amputations with HBOT. This lowers attendant medical costs including prosthetics and increases the quality of life for these patients because they can keep their feet. In 2006, VA was doing nearly 3,000 diabetic foot amputations per year. At a Medicare cost of $30,000 each, that is $90 million. If we prevent 75% of those amputations, the surgical savings would be $67.5 million per year, with HBOT therapy costing 1/2 of the surgical costs.
  • There are 10,000 hyperbaric oxygen treatments per day in the U.S. to cause healing in non-healing wounds at 1,000 locations in America -- except in the VA.
  • Comparative costs: Consider the economic impact of coronary heart disease (CHD) and stroke

The total US economic cost of coronary heart disease (CHD) is estimated to be $ 111.8 billion for 2002. Direct costs ($ 58.2 billion) include: hospitals and nursing homes ($ 41.8 billion); physicians and other professional services ($ 8.6 billion); medications/other durables ($ 6.2 billion), and home health care ($ 1.6 billion). Indirect costs ($ 53.6 billion) include the loss of productivity due to morbidity ($ 8.4 billion) and mortality ($ 45.2 billion). The total US economic cost of stroke for the year 2002 is projected to be $ 49.4 billion. Direct costs are projected at $ 30.8 billion, which include those associated with hospitals and nursing homes ($ 24.5 billion); physicians and other professional services ($ 2.4 billion); drugs/other medical durables ($ 800 million), and home health care ($ 3.1 billion). Indirect costs, which include costs associated with the loss of productivity due to morbidity ($ 5.6 billion) and mortality ($ 13.0 billion) are projected at $ 18.6 billion. The considerable economic cost associated with CHD and stroke underscores the need for preventive education to raise awareness among at-risk patients concerning the warning signs of stroke, the importance of lifestyle modifications, and the availability of effective therapies.






Copyright 2009 by NBIRR Clinical Trial - Fundraiser Privacy StatementTerms Of Use Xhtml 1.0 CSS 2.0